Finished
HPI Effect in Robotic Urological Surgery on AKI
NCT06051162 · Ewha Womans University Mokdong Hospital · Updated 8 Sept 2026
- What is being tested
- BP management with HPI guidance
- For
- Prostate Cancer; Renal Cancer; Urologic Diseases
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 19 years and older. About 124 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 7 Nov 2023, ends 10 April 2025. Registered 22 Sept 2023.
- Results
- None posted yet.
In the researchers' words
It is a single-center randomized controlled trial that aims to figure out the effect of the hypotension prediction index (HPI) on the prevention of acute kidney injury (AKI) after robot-assisted urological surgery. The primary hypothesis is that HPI software guidance prevents postoperative AKI by reducing the duration and severity of intraoperative hypotension (IOH).
Sites
- Ewha Womans University Mokdong HospitalSeoul, Seoul, South Korea